Interest of Nurse Participation During Epicutaneous-cavity Catheter Placement in Neonatal Intensive Care
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Feb 3, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how having a nurse help a doctor during the placement of a special IV (called a KTEC) can affect the number of attempts needed and the pain experienced by premature babies in the neonatal intensive care unit (NICU). The trial is based on the idea that when a nurse and doctor work together, it might be easier to insert the IV, which could mean fewer needle pokes and less pain for the newborn. The researchers want to see if this "four hands" approach is better than the usual method where only the doctor does the procedure.
To participate in the study, newborns who are between 25 and 42 weeks old and need this IV inserted can be included, provided their parents or guardians are informed about the study and can give consent. The study aims to improve the comfort of these vulnerable babies by potentially reducing their pain during a necessary medical procedure. If you are considering participation, you should know that the trial is not yet recruiting participants, but it could be an important step towards better care for premature infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newborns born between 25 and 42 weeks of amenorrhea requiring KTEC insertion
- • Newborn whose parents or guardians have been informed of the study and are capable of providing informed consent to participate in the research.
- • Informed consent obtained from parents or guardians
- • Parents of legal age (≥18 years)
- Exclusion Criteria:
- • Parents under guardianship or curatorship, deprived of liberty or under court protection
- • Parents who do not speak or understand French
- • Newborn born under X
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Nathalie SATURNIN LENOBLE
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported